These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Thyrotoxic cardiomyopathy. Analysis of 190 cases of thyrotoxicosis]. Hrnciar J Cas Lek Cesk; 1972 Jun; 111(25):575-80. PubMed ID: 5036055 [No Abstract] [Full Text] [Related]
4. Thyrotoxic cardiomyopathy complicated by systemic and pulmonary embolism. Hausmann W Proc R Soc Med; 1975 May; 68(5):327. PubMed ID: 1215421 [No Abstract] [Full Text] [Related]
5. [Endocrine cardiomyopathies diagnosed accidentally in an outpatient clinic for arrhythmias]. Apitz H; Wirth J Z Arztl Fortbild (Jena); 1980 Sep; 74(18):848-52. PubMed ID: 7467447 [No Abstract] [Full Text] [Related]
6. [Thyroid cardiac diseases in the African hospital milieu: experience of the Principal Hospital of Dakar, Senegal]. Thiam M; Mbaye PS; Camara P; Cloatre G; Perret JL Med Trop (Mars); 1999; 59(2):173-5. PubMed ID: 10546193 [TBL] [Abstract][Full Text] [Related]
7. [Myocardial necrosis caused by hyperthyroid crisis]. Contreras R; Cárdenas M; Lerdo de Tejada Hay A; Serrano Maass PA Arch Inst Cardiol Mex; 1965; 35(5):681-91. PubMed ID: 5859328 [No Abstract] [Full Text] [Related]
8. Heart damage in thyrotoxicosis and implication of ischemic disease of the heart - questions about pathogenesis, diagnosis and treatment. Felt V Czech Med; 1983; 6(3):175-7. PubMed ID: 6416795 [No Abstract] [Full Text] [Related]
9. [Hyperthyroidism with destructive myocardial changes observed by means of endomyocardial biopsy. Report of a case]. Morimoto S; Matsumura K; Osamura Y; Harada M; Komatsu Y; Sekiguchi M Kokyu To Junkan; 1982 Sep; 30(9):953-8. PubMed ID: 7178699 [No Abstract] [Full Text] [Related]
10. [Cardiac involvement in hyperthyroidism. Study of 78 cases and physiopathologic review]. Ribera Casado JM; Rodríguez Zapata M; Palau Beato E; Villarroel González-Elipe P; Chicharro Papiri A Rev Clin Esp; 1982 Mar; 164(6):363-7. PubMed ID: 7111801 [No Abstract] [Full Text] [Related]
11. [Cardiac involvement in thyrotoxicosis and aging. Sphygmographic study]. Felt V; Cenková V Cas Lek Cesk; 1983 Apr; 122(17):522-5. PubMed ID: 6850725 [No Abstract] [Full Text] [Related]
13. [The importance of magnesium in preventing myocardial metabolic disorders in thyrotoxicosis]. Golber LM; Anan'eva KA; Kandror VI; Kriukova IV; Negovskaia AV Biull Eksp Biol Med; 1969 Mar; 67(3):23-6. PubMed ID: 5821450 [No Abstract] [Full Text] [Related]
14. [Hyperthyroidism and heart disease. Is thyrotoxic cardiomyopathy a disease entity?]. Toft P; Bøtker HE Ugeskr Laeger; 1993 May; 155(18):1354-7. PubMed ID: 8497965 [TBL] [Abstract][Full Text] [Related]
15. [Secondary myocardial disease]. Chen ZJ Zhonghua Nei Ke Za Zhi; 1984 Jun; 23(6):384-6. PubMed ID: 6510138 [No Abstract] [Full Text] [Related]
16. [Cor thyreotoxicum. Part I--new findings about its etiopathogenesis and diagnosis. Overview of problems based on 35 years' experience]. Hrnciar J Vnitr Lek; 2002 Jan; 48(1):38-44. PubMed ID: 11852586 [TBL] [Abstract][Full Text] [Related]
17. [Reversible dilated cardiomyopathy and hyperthyroidism]. Rodríguez Blanco VM; Barriales Alvarez V; Segovia Martínez E; Morís de la Tassa C; Barriales Villa R; Cortina Llosa A Rev Esp Cardiol; 1996 Oct; 49(10):770-2. PubMed ID: 9036481 [TBL] [Abstract][Full Text] [Related]
18. [Current knowledge of cardiomyopathy]. Stojsić D; Stojsić-Milosavljević A Med Pregl; 1997; 50(11-12):481-5. PubMed ID: 9471507 [TBL] [Abstract][Full Text] [Related]